drugset / Trial / NCT05426148
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Phase 4
Completed
540 enrolled
Xiamen Innovax Biotech Co., Ltd
Dongtai City Centers for Disease Control and Prevention · collabJiangsu Province Centers for Disease Control and Prevention · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
This study is to evaluate lot-lot consistency of Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) .
Timeline
- Start
- 2020-05-01
- Primary completion
- 2020-08-01
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine (Escherichia coli) | Vaccine | 0.5 ml | Intramuscular |